Press Releases

Since 2007, DaVita has raised millions and impacted thousands globally through annual activity-based events DENVER, Nov. 30, 2023 /PRNewswire/ -- DaVita, a leading provider of kidney care...

DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2023. "We delivered another strong quarter," said Javier Rodriguez, CEO of DaVita Inc. "We...

Research includes studies designed to overcome barriers to living donation and in-home treatment among African American and Spanish-speaking Mexican American patients DENVER and PHILADELPHIA, Nov....

DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Tuesday, November 7, 2023, at 5:00 p.m. Eastern Time. The company plans...

DaVita issued the following statement in response to news this week from Novo Nordisk, manufacturer of Ozempic®, a glucagon-like peptide 1 (GLP-1) receptor agonist indicated for type 2 diabetes,...

Kidney care provider invests in early detection and prevention to help reduce progression of chronic kidney disease in key communities it serves DENVER, Sept. 13, 2023 /PRNewswire/ -- DaVita Inc....

Collaboration includes launch of new nursing curriculum that increases access to career pathways post-graduation DENVER, Sept. 12, 2023 /PRNewswire/ -- DaVita Inc., a leading kidney care provider,...

DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat hosted...

For the most up-to-date information on how Hurricane Idalia has affected your DaVita center, please call DaVita Guest Services at 1-800-400-8331. Hurricane Idalia is anticipated to make landfall...

DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended June 30, 2023. "Over the first half of the year, DaVita has been focused on innovation in our clinical...

DaVita Inc. today announced that its Board of Directors appointed a new independent director, Wendy Schoppert, to join the Board, effective as of July 14, 2023. "We're pleased to welcome Wendy to...

DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Thursday, August 3rd, 2023, at 5:00 p.m. Eastern Time. The company...

Recognizes nurses who further DaVita's mission to be the provider and employer of choice. DENVER, May 10, 2023 /PRNewswire/ -- DaVita Inc. today announced that 56 of its nephrology nurses were...

DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March 31, 2023. "In the first quarter, we performed well on our key metrics and our results benefited from...

DaVita Inc. today published its 2022 Community Care Report, reinforcing its long-standing commitment to corporate citizenship and highlighting meaningful progress made toward meeting the 2025...

DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, will participate in a fireside chat with investors at the BofA Securities Healthcare Conference 2023 on...

DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Monday, May 8, 2023, at 5:00 p.m. Eastern Time. The company plans to...

Medtronic plc (NYSE: MDT) and DaVita Inc. (NYSE: DVA) today announced the launch of Mozarc Medical—an independent new company committed to reshaping kidney health and driving patient-centered...

DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, will participate in a fireside chat with investors at the Barclays 2023 Global Healthcare Conference on...

DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter and year ended December 31, 2022. "We continue to have excitement and conviction in our long-term capabilities and...

DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter and full year results on Wednesday, February 22, 2023, at 5:00 p.m. Eastern Time....

Today, DaVita recognizes the impact its employees, known as teammates, had on kidney care in 2022. Over the last year, DaVita made strides in innovation and clinical excellence while uplifting the...

The event has raised nearly $15 million for the nonprofit since 2007, enabling Bridge of Life to enhance kidney care globally through its medical missions. DENVER, Dec. 20, 2022 /PRNewswire/ -- Today,

Tropical Storm Nicole is expected to make landfall in Florida on November 10, potentially bringing severe storm conditions to a large portion of the southeastern U.S. DaVita’s care teams across...

This year's research centered on advancements in kidney transplantation and equity in patient care DaVita addresses equitable access to breakthrough trials and decentralized research by...

DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2022. "The third quarter was a challenging quarter for us. Like others in the healthcare...

DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Friday, October 28, 2022, at 8:30 a.m. Eastern Time. The company plans...

Grant to enable nonprofit organizations in the Food Is Medicine Coalition to expand services for medically-tailored meals for individuals with chronic medical conditions. DENVER, Oct. 10, 2022...

Hurricane Ian made landfall in Florida on September 28, bringing severe storm conditions to a large portion of the state. The storm is now moving towards Georgia and the Carolinas, and expected to...

DaVita Inc. announced today that its Board of Directors appointed a new independent director, Adam H. Schechter, to join the Board, effective September 20, 2022. Mr. Schechter is the President,...

DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended June 30, 2022. "We are living in a dynamic time with a sustained global pandemic, labor shortage, supply...

DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Monday, August 1, 2022, at 5:00 p.m. Eastern Time. The company plans...

DaVita Inc. (NYSE: DVA), announced today it will hold a special conference call with investors on Thursday, June 23, 2022, at 8:45 a.m. Eastern Time. This call follows this week's U.S. Supreme...

Companies join forces to accelerate kidney care device innovation and improve patient outcomes DUBLIN and DENVER, May 26, 2022 /PRNewswire/ -- Medtronic plc (NYSE: MDT) and DaVita Inc. (NYSE: DVA)...

DaVita today announced that 56 of its nephrology nurses were honored with the DAISY Award® for Extraordinary Nurses during National Nurses Week. The award is part of the DAISY Foundation's™...

DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, will participate in a fireside chat with investors at the Bank of America Securities 2022 Healthcare...

DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March 31, 2022. For the quarter, diluted earnings per share was $1.61, a decrease of (10.1)% from the prior...

Today, DaVita Inc. highlighted its continued commitment to corporate citizenship with the publication of its annual Community Care Environmental Social Governance (ESG) Report. "I'm humbled...

DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Thursday, May 5, 2022, at 5 p.m. Eastern Time. The company plans to...

DaVita Inc. announced today that its board of directors appointed a new independent director, Jason M. Hollar, to join the board, effective May 6, 2022. Mr. Hollar brings more than 25 years of...

Results demonstrate the importance of vaccinating patients at trusted sites of care DENVER and WALTHAM, Mass., April 4, 2022 /PRNewswire/ -- A federal partnership established to help increase...

Dialysis patients who received an adenovirus vector-based COVID-19 vaccine (Johnson & Johnson) were found to have similar rates of breakthrough infection, hospitalization and mortality as dialysis...

DaVita Kidney Care today announced Dr. Mihran Naljayan as chief medical officer (CMO) of Home Modalities. Dr. Naljayan joined DaVita in 2016 and most recently served as vice president of clinical...

In honor of National Donor Day—and every living organ donor—DaVita announced it increased paid leave for organ donation to four consecutive weeks for benefits-eligible teammates (employees)...

DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter and year ended December 31, 2021. "COVID continues to evolve and have a direct impact on our world, especially on...

Beginning Sunday, areas in the Southeast and along the East Coast will experience inclement winter weather, which is expected to go through Monday. Communities in northeast Georgia, the Carolinas...

DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter results on Thursday, February 10, 2022, at 5:00 p.m. Eastern Time. The company...

DaVita Integrated Kidney Care (DaVita IKC)—along with nearly 1,000 kidney doctors, transplant providers, hospice providers and advanced care practitioners—today announced the launch of 11...

DaVita Inc. today announced its acquisition of transplant software company MedSleuth. Working with transplant centers across the U.S., MedSleuth aims to create greater connectivity among...

DaVita today celebrated its teammates (employees) for their contributions that helped improve the lives of kidney patients, advance innovation in kidney care and better serve communities around...